Detalhe da pesquisa
1.
A Non-Canonical Function of Gß as a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation.
Mol Cell
; 58(5): 794-803, 2015 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25982117
2.
Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma.
J Hepatol
; 74(4): 907-918, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031845
3.
Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth.
Mol Cell
; 42(6): 719-30, 2011 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21700219
4.
Erratum to 'Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma' [J Hepatol 2021 (907-918)].
J Hepatol
; 77(2): 580, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489965
5.
Correction: TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition.
J Biol Chem
; 294(15): 5808, 2019 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30979850
6.
Correction: The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFß-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition.
J Biol Chem
; 294(15): 5809, 2019 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30979851
7.
Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer.
Signal Transduct Target Ther
; 9(1): 65, 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461173
8.
Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages.
Cell Rep Med
; 5(4): 101489, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554705
9.
The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFß-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition.
J Biol Chem
; 287(31): 26245-53, 2012 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22692215
10.
The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.
J Biol Chem
; 285(48): 37159-69, 2010 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20858893
11.
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion.
J Clin Invest
; 129(8): 3324-3338, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31305264
12.
Deglycosylation of PD-L1 by 2-deoxyglucose reverses PARP inhibitor-induced immunosuppression in triple-negative breast cancer.
Am J Cancer Res
; 8(9): 1837-1846, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323975
13.
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.
Cancer Cell
; 34(6): 954-969.e4, 2018 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537515
14.
Hypertension-associated C825T polymorphism impairs the function of Gß3 to target GRK2 ubiquitination.
Cell Discov
; 2: 16005, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27462452
15.
TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition.
J Biol Chem
; 284(20): 13355-13362, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19324877
16.
Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.
Science
; 324(5924): 261-5, 2009 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19359588
17.
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.
Mol Cell Biol
; 28(7): 2426-36, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18227151